Immunotherapies for NEUROINFLAMMATION
in diseases driven by

Therini Bio is developing a pioneering approach based on world-class science to halt chronic neuroinflammation and neuronal damage caused by vascular injury to treat severe neurological and retinal diseases.

Therini Bio
We are advancing a novel, clinical-stage pipeline focused on selectively targeting toxic fibrin deposits that trigger inflammation cascades and underlie numerous diseases, including Alzheimer’s Disease and Diabetic Macular Edema.

Our experienced team is dedicated to efficiently progressing our candidates through the clinic to potentially improve the lives of people suffering from neurodegenerative diseases driven by vascular dysfunction.

We are backed by a top-tier syndicate of investors in life sciences and neurodegenerative diseases

ADDF logo
DDF logo
Dreavent logo
foundation for a better world logo
Lilly logo
MRL ventures fund logo
sanofi ventures logo
SV Health Investors logo